Tandem Diabetes Care, Inc. – NASDAQ:TNDM
Tandem Diabetes Care stock price today
$10.89
-25.99
-70.47%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 5 hours
Tandem Diabetes Care stock price monthly change
-19.95%
month
Tandem Diabetes Care stock price quarterly change
-19.95%
quarter
Tandem Diabetes Care stock price yearly change
+19.28%
year
Tandem Diabetes Care key metrics
Market Cap | 2.31B |
Enterprise value | 2.97B |
P/E | -28.69 |
EV/Sales | 3.70 |
EV/EBITDA | -43.60 |
Price/Sales | 3.39 |
Price/Book | 6.19 |
PEG ratio | 0.04 |
EPS | -2.17 |
Revenue | 770.00M |
EBITDA | -124.02M |
Income | -141.45M |
Revenue Q/Q | 13.16% |
Revenue Y/Y | -3.10% |
Profit margin | -11.81% |
Oper. margin | -11.59% |
Gross margin | 51.54% |
EBIT margin | -11.59% |
EBITDA margin | -16.11% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTandem Diabetes Care stock price history
Tandem Diabetes Care stock forecast
Tandem Diabetes Care financial statements
Average Price Target
$49.88
Potential upside: 357.98%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 195.91M | -35.77M | -18.26% |
|---|---|---|---|
| Sep 2023 | 185.62M | -32.96M | -17.76% |
| Dec 2023 | 196.79M | -30.00M | -15.25% |
| Mar 2024 | 191.67M | -42.71M | -22.29% |
| Jun 2023 | 946676000 | 617.44M | 65.22% |
|---|---|---|---|
| Sep 2023 | 939909000 | 625.90M | 66.59% |
| Dec 2023 | 952658000 | 639.02M | 67.08% |
| Mar 2024 | 941045000 | 697.98M | 74.17% |
| Jun 2023 | -6.32M | 5.69M | 3.94M |
|---|---|---|---|
| Sep 2023 | 55K | -48.52M | -1.91M |
| Dec 2023 | -7.21M | -16.58M | 2.61M |
| Mar 2024 | -7.99M | -5.05M | 13.58M |
Tandem Diabetes Care alternative data
| Aug 2023 | 2,600 |
|---|---|
| Sep 2023 | 2,600 |
| Oct 2023 | 2,600 |
| Nov 2023 | 2,600 |
| Dec 2023 | 2,600 |
| Jan 2024 | 2,600 |
| Feb 2024 | 2,600 |
| Mar 2024 | 2,400 |
| Apr 2024 | 2,400 |
| May 2024 | 2,400 |
| Jun 2024 | 2,400 |
| Jul 2024 | 2,400 |
Tandem Diabetes Care other data
89.25%
-4.01%
of TNDM is owned by hedge funds
368
-14
58.83M
-1.57M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2024 | 532 | 40000 |
| Patent |
|---|
Application Filling date: 22 Feb 2022 Issue date: 25 Aug 2022 |
Application Filling date: 28 Jan 2022 Issue date: 28 Jul 2022 |
Application Filling date: 7 Apr 2022 Issue date: 21 Jul 2022 |
Application Filling date: 7 Apr 2022 Issue date: 21 Jul 2022 |
Application Filling date: 5 Apr 2022 Issue date: 21 Jul 2022 |
Application Filling date: 12 Jan 2022 Issue date: 14 Jul 2022 |
Grant Filling date: 18 Jun 2019 Issue date: 12 Jul 2022 |
Grant Filling date: 7 Feb 2019 Issue date: 21 Jun 2022 |
Application Filling date: 8 Mar 2022 Issue date: 16 Jun 2022 |
Application Filling date: 10 Feb 2022 Issue date: 26 May 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 21 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 1 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here
DexCom: Attractive Discount After Strong Earnings Results
8 Tax-Loss Sell Alerts For December
Insulet Corporation: Still No Bargain
Why Medtronic Could Have 25% Upside From Today's Levels
Diabetes Deep-Dive With DexCom And Embecta: Polar Opposite Diabetes Plays
Tandem Diabetes Care: Undervalued Technology Leader
Tandem Diabetes Care: Strong Financials And Revenue, Overpenalized For Missed Earnings
The Correction In Biopharmaceutical Stocks Is Likely Over
-
What's the price of Tandem Diabetes Care stock today?
One share of Tandem Diabetes Care stock can currently be purchased for approximately $10.89.
-
When is Tandem Diabetes Care's next earnings date?
Unfortunately, Tandem Diabetes Care's (TNDM) next earnings date is currently unknown.
-
Does Tandem Diabetes Care pay dividends?
No, Tandem Diabetes Care does not pay dividends.
-
How much money does Tandem Diabetes Care make?
Tandem Diabetes Care has a market capitalization of 2.31B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6.68% to 747.72M US dollars.
-
What is Tandem Diabetes Care's stock symbol?
Tandem Diabetes Care, Inc. is traded on the NASDAQ under the ticker symbol "TNDM".
-
What is Tandem Diabetes Care's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Tandem Diabetes Care?
Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Tandem Diabetes Care's key executives?
Tandem Diabetes Care's management team includes the following people:
- Mr. John F. Sheridan Pres, Chief Executive Officer & Director(age: 70, pay: $1,090,000)
- Mr. Brian B. Hansen Executive Vice President & Chief Commercial Officer(age: 57, pay: $618,650)
- Ms. Leigh A. Vosseller Executive Vice President, Chief Financial Officer & Treasurer(age: 52, pay: $618,170)
- Mr. David B. Berger Executive Vice President, Chief Bus. Operations & Compliance Officer and Corporation Sec.(age: 55, pay: $617,650)
- Ms. Susan M. Morrison Executive Vice President & Chief Admin. Officer(age: 46, pay: $616,870)
-
How many employees does Tandem Diabetes Care have?
As Jul 2024, Tandem Diabetes Care employs 2,400 workers.
-
When Tandem Diabetes Care went public?
Tandem Diabetes Care, Inc. is publicly traded company for more then 11 years since IPO on 14 Nov 2013.
-
What is Tandem Diabetes Care's official website?
The official website for Tandem Diabetes Care is tandemdiabetes.com.
-
Where are Tandem Diabetes Care's headquarters?
Tandem Diabetes Care is headquartered at 11075 Roselle Street, San Diego, CA.
-
How can i contact Tandem Diabetes Care?
Tandem Diabetes Care's mailing address is 11075 Roselle Street, San Diego, CA and company can be reached via phone at 858 366 6900.
-
What is Tandem Diabetes Care stock forecast & price target?
Based on 7 Wall Street analysts` predicted price targets for Tandem Diabetes Care in the last 12 months, the avarage price target is $49.88. The average price target represents a 357.98% change from the last price of $10.89.
Tandem Diabetes Care company profile:
Tandem Diabetes Care, Inc.
tandemdiabetes.comExchange:
NASDAQ
Full time employees:
2,400
Industry:
Medical - Devices
Sector:
Healthcare
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
11075 Roselle Street
San Diego, CA 92121
San Diego, CA 92121
CIK: 0001438133
ISIN: US8753722037
CUSIP: 875372203
